ENTITY

SciSparc (SPRC US)

83
Analysis
Health Care • Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
•14 Oct 2026 10:37•Broker

SET Index Outlook

(-) US September core CPI is expected to rise to 2.50% from 2.40% in August, weighing on stock market sentiment today. (-)Brent remains elevated...

Logo
21 Views
Share
bullish•SciSparc
•02 Oct 2026 14:56•Broker

KTX Tactical Picks

We recommend taking profit on SPRC after a 23.2% holding-period return, exceeding our target, and adding BGRIM and COM7 to the portfolio. The...

Logo
84 Views
Share
•08 Oct 2026 14:21•Broker

SET Index Outlook

Crude prices remain elevated on tight supply. US long-term bond yields hit a 24-year high, benefiting banks and insurers and supporting further US...

Logo
89 Views
Share
bullish•SciSparc
•03 Sep 2026 15:19•Broker

Energy (Upstream-Downstream): Valuation Stretched; Accumulate Sustainable High Dividend and Story-Driven Plays on Weakness – Neutral

Geopolitical risk remains a trading catalyst and provides downside support for both upstream and downstream stocks. However, strong YTD...

Logo
95 Views
Share
•05 Oct 2026 12:20•Broker

SET Index Outlook

(+)The CME FedWatch Tool shows a 22.1% probability of an October Fed rate hike, down from 64.2% the previous week, following weaker-than-expected...

Logo
89 Views
Share
x